Global Metagenomics Market Report and Forecast 2024-2032

Global Metagenomics Market Outlook

The global metagenomics market size was valued at USD 738.1 million in 2023, driven by the rising emphasis on dealing with antibiotic resistance. The market is expected to grow at a CAGR of 14.2% during the forecast period of 2024-2032, with the values likely to rise from USD 842.5 million in 2024 to USD 2429.3 million by 2032.

Metagenomics: Introduction

Metagenomics is the study of complex microbial communities in their natural habitat. It involves whole genome sequencing analysis of an entire community of microorganisms that may be present on and in the body (animals, humans, fish, or insects), air, soil, water samples and food. Metagenomics involves several tools, techniques, and approaches that allow direct and total genetic analysis. It is widely recommended as it allows the diagnosis of unculturable microorganisms via genomic assemblies.

Global Metagenomics Market Analysis

Metagenomics has found its application in several domains, including climate challenges, clinical diagnostics, food and nutrition, veterinary diagnostics and more. Consequently, the demand has seen a significant pick-up in recent years. The metagenomics market growth is driven by the advent of technically advanced techniques like targeted metagenomic sequencing and shotgun sequencing.

With the growing prevalence of chronic illnesses, there has been significant concentration on speeding up drug development across the globe. In May 2023, Ginkgo Bioworks and Boehringer Ingelheim entered a strategic partnership to put Ginkgo’s metagenomic sequence database to use and search and accelerate the drug discovery process, particularly for ailments with unmet patient needs. Such mergers are a clear indication that the metagenomics market demand will witness substantial progress during the forecast period.

The market growth is driven by the increasing emphasis on combating antimicrobial resistance. Antibiotic resistance bloodstream infections have been a growing area of concern amongst scientists. Bloodstream infections may lead to multiple organ failure, sepsis and even death, as a result, early and apt therapy is highly critical to control the infection. When compared to conventional methods, metagenomic sequencing provides rapid and precise research results, making it a preferred alternative for researchers.

Global Metagenomics Market Segmentation

Market Breakup by Product and Services

• Software

• Kits and Reagents

• Sequencing and Data Analytics Service

Market Breakup by Technology

• Shotgun Sequencing

• 16S Sequencing

• Whole Genome Sequencing

• Others

Market Breakup by Application

• Environmental Application

• Clinical Diagnostics Applications

• Soil Microbiome Applications

• Drug Discovery Applications

• Biotechnology Applications

• Food and Nutrition Applications

• Veterinary Applications

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Metagenomics Market Overview

The United States accounted for a significant part of the metagenomics market share during the historical period. The market share can be attributed to the region’s well-structured pharmaceutical and biotechnology industries, along with increasing government funding for genomics research. The rising focus of key healthcare players around offering personalised medicine to patients has also been contributing significantly to the market growth.

Europe has been historically dominating the global market with a robust healthcare and research infrastructure. Projects like the MetaHIT, which aimed at leveraging metagenomics to establish relations between the genes of the human intestinal microbiota, along with health and disease, can be a prime example demonstrating the region’s commitment to promoting innovation amongst researchers.

The Asia Pacific metagenomics market value is projected to emerge strongly in upcoming years. With increasing awareness and investigations into genomic research, the research is expanding the infrastructure for better facilities. The potential applications of metagenomics across various domains including agricultural and environmental studies have led to boosted research initiatives and funding for the same.

Global Metagenomics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Agilent Technologies, Inc

• ENTEROME

• IntegraGen

• Oxford Nanopore Technologies

• QIAGEN

• Illumina, Inc

• Pacific Biosciences of California, Inc

• Swift Biosciences Inc.

• Thermo Fisher Scientific Inc.

• BGI

• Bio-Rad Laboratories, Inc.

• Promega Corporation

• Computomics Gmbh.

• Microsynth AG

• Arc Bio LLC

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report